Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myocet and Taxotere in Metastatic HER2/Neu Negative Breast Cancer
NCT00377559Phase 2Completed
- Sponsor
- Catharina Ziekenhuis
- Start
- May 2006
- Primary completion
- Nov 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, docetaxel in breast cancer, sponsored by Catharina Ziekenhuis. Started May 2006; status: completed.
02
Drugs
doxorubicindocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00377559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00377559.